Shuttle Pharmaceuticals Corrects Number of Pre-Funded Warrants Issued

What Happened
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) filed a Form 8-K/A on September 24, 2026 to amend its previous Form 8-K regarding unregistered sales of equity securities. The company clarified that, as of September 9, 2026, it has actually issued 9,741,751 pre-funded warrants to purchase shares of its common stock. The earlier filing had referenced approximately 16,932,508 pre-funded warrants as the maximum number that could be issued upon satisfaction of conditions, not the number actually issued.

Key Details

• Amendment filed: Form 8-K/A on September 24, 2026 (correcting the September 9, 2026 disclosure).
• Actual pre-funded warrants issued as of Sept 9, 2026: 9,741,751.
• Previously reported figure (~16,932,508) represented the maximum potential number, not the issued amount.
• Change relates to Item 3.02 (Unregistered Sales of Equity Securities); the amendment is limited to correcting the issuance count.

Why It Matters
This correction affects the calculation of outstanding and potentially dilutive securities. Investors estimating fully diluted share counts or ownership percentages should use the corrected issued-warrant number (9,741,751) rather than the larger maximum figure previously cited. The amendment does not change other terms disclosed about the warrants; for full detail on exercise price, vesting or conversion mechanics, investors should review the company’s related filings.